Pengkai Ma
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- RNA Interference and Gene Delivery 2
-
- Nanoparticle-Based Drug Delivery 5
- Co-authors
- Hongyu Zhu (5 shared papers)Yujie Zhang (4 shared papers)Xing Gao (5 shared papers)Jianhua Chen (3 shared papers)Kaoxiang Sun (2 shared papers)Ling Ni (2 shared papers)Zhihui Li (1 shared paper)Jing Qi (1 shared paper)
- Journals
- Drug Delivery (4 papers)PLoS ONE (1 paper)Journal of Ethnopharmacology (1 paper)Pharmaceutical Research (1 paper)International Journal of Nanomedicine (1 paper)
- Partner nations
- China
In The Last Decade
Pengkai Ma
20 papers receiving 307 citations
Peers
Comparison fields: 5 of 67
- Biomaterials 85
- Hepatology 22
- Polymers and Plastics 36
- Complementary and alternative medicine 19
- Pharmacology 19
Countries citing papers authored by Pengkai Ma
This map shows the geographic impact of Pengkai Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengkai Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengkai Ma more than expected).
Fields of papers citing papers by Pengkai Ma
This network shows the impact of papers produced by Pengkai Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengkai Ma. The network helps show where Pengkai Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Pengkai Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 73 | |
| 2 | 2015 | 34 | |
| 3 | 2017 | 27 | |
| 4 | 2016 | 22 | |
| 5 | 2021 | 21 | |
| 6 | 2016 | 21 | |
| 7 | 2021 | 18 | |
| 8 | 2018 | 14 | |
| 9 | 2021 | 14 | |
| 10 | 2020 | 12 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 10 | |
| 13 | 2014 | 7 | |
| 14 | 2022 | 7 | |
| 15 | 2020 | 5 | |
| 16 | 2024 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2016 | 2 | |
| 19 | 2017 | 2 | |
| 20 | 2022 | 1 |
About Pengkai Ma
Pengkai Ma is a scholar working on Molecular Biology, Biomaterials, Pharmacology, Pharmacology and Cancer Research, having authored 20 papers that have together received 309 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Nanoplatforms for cancer theranostics (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Berberine and alkaloids research (2 papers), RNA Interference and Gene Delivery (2 papers), Flavonoids in Medical Research (2 papers) and Plant-based Medicinal Research (2 papers). The work is most often cited by research in Biomaterials (85 citations), Hepatology (22 citations), Polymers and Plastics (36 citations), Complementary and alternative medicine (19 citations) and Pharmacology (19 citations). Pengkai Ma has collaborated with scholars based in China. Frequent co-authors include Hongyu Zhu, Yujie Zhang, Xing Gao, Jianhua Chen, Kaoxiang Sun, Ling Ni, Zhihui Li, Jing Qi, Jinming Li and Xuemei Zhang. Their work appears in journals such as Drug Delivery, PLoS ONE, Journal of Ethnopharmacology, Pharmaceutical Research and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.